ACC-015

N/A

Report date: 2022/12/07 17:52:59
NME

Base Information

Drug NameACC-015
Drug Alias NameACC-015
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Nucleoside analogues
Mechanisms of ActionDNA-directed DNA polymerase inhibitors
TargetsDNA-directed DNA polymerase
Therapy Area/IndicationsSolid tumoursLeukemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesJiangsu Aidea Pharmaceutical Group Co LtdKainos Medicine Inc
China Registration ClassN/A

Develop Information

Active CompaniesKainos Medicine IncJiangsu Aidea Pharmaceutical Group Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursLeukemia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A